safest glp 1 drugs for weight loss Comparing Ozempic, Wegovy and Other GLP-1 What to Make of the

Obesity is a complex disease, excessive fat accumulation caused by genetic, environmental and other factors, that has seen the most rapid growth in terms of ...

Tirzepatide), metabolic outcomes, and next-gen weight loss benefits

National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)

Here the authors report that D-allulose triggers GLP-1 release in the gut and GLP-1R signaling on vagal afferents, counteracting arrhythmic overeating, obesity and diabetes.

Compare early results with Wegovy and Mounjaro.

Allulose in human diet: the knowns and the unknowns - Volume 128 Issue 2